Nicardipine given through a lumbar drain after a ruptured brain aneurysm bleed
Tests nicardipine in spinal fluid to prevent vasospasm in adults with aneurysm-related brain bleeding.
Key facts
- Who runs it
- Wake Forest University Health Sciences
- Where
- Park Ridge, United StatesSee the site
- Trial code
- Registry title
- Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 214 people, planned
- Starts
- Jan 2027
- Expected to end
- Mar 2028
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Normal Saline
- Nicardipine
- Record updated
- 1 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with bleeding around the brain caused by a burst brain aneurysm (a bulge in a blood vessel). It tests nicardipine given through a lower-back drain into the spinal fluid to prevent narrowing of brain blood vessels.
- Age
- 18 years and older
- Sex
- All sexes
- Disease stage
- Bleeding around the brain (subarachnoid hemorrhage) from a burst aneurysm, with a Hunt and Hess score of 3 or less. Before the bleed, people had no or only slight disability (modified Rankin scale 0 or 1).
- Earlier treatment
- People must have a lower-back (lumbar) drain for spinal fluid already placed or planned as part of standard care. They must be able to join within 72 hours of arrival or within 24 hours of drain placement.
Main reasons for not taking part
- Pregnant women
- Hunt and Hess score above 3, or bleeding not caused by a burst aneurysm
- Allergy to dihydropyridines or other reasons calcium channel blockers cannot be used
- Active or strongly suspected infection of the brain or spinal cord
- Unstable blood pressure or circulation that prevents use of Nicardipine
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Age ≥18 years
- Aneurysmal subarachnoid hemorrhage with Hunt and Hess score 3 or less
- Patient or legal authorized representative available to sign the informed consent form
- Pre-morbid modified Rankin scale of 0 or 1
- Patients who have lumbar drain placed or planned for cerebrospinal fluid diversion per standard of care
- Patients who are able to be randomized within 72 hours from arrival with aneurysmal subarachnoid hemorrhage or within 24 hours from lumbar drain placement
Who cannot take part
- Subarachnoid hemorrhage (SAH) with hunt and hess scale of >3
- Active central nerve infection (CNS) infection or high suspicion of CNS infection
- Any contraindications in patients receiving calcium channel antagonists like hypersensitivity to dihydropyridines
- Pregnant females
- SAH due to etiology other than aneurysmal rupture
- Hemodynamic instability preventing the use of Nicardipine
Where in United States
- Advocate Lutheran General HospitalPark Ridge, United StatesContact: Sajid Suriya, MDNot yet recruiting
About the trial
What the trial wants to find out
The purpose of this study is to determine the effectiveness of prophylactic administration of intra-thecal nicardipine though lumbar cerebrospinal fluid drain in prevention of symptomatic vasospasm in patients with subarachnoid hemorrhage due to rupture of cerebral aneurysms.
The 2 groups in the trial
- Standard of CareSham treatment, for comparison
standard treatment of cerebral vasospasm and sham injection of 10 mL preservative-free normal saline in luer-lock sterile syringe
Treatment: Normal Saline
- Standard of Care Plus NicardipineTreatment being tested
standard treatment of cerebral vasospasm with prophylactic administration of intrathecal nicardipine
Treatment: Nicardipine
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prophylactic Use of Intrathecal Calcium Channel Antagonist Through Lumbar Drain in Patients With Subarachnoid Hemorrhage Due to Aneurysmal Rupture
- Plain-language title
- Nicardipine given through a lumbar drain after a ruptured brain aneurysm bleedGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 1 October 2026